NeoPharm CO., LTD. (092730.KQ)

KRW 11960.0

(-0.33%)

Total Debt Summary of NeoPharm CO., LTD.

  • NeoPharm CO., LTD.'s latest annual total debt in 2023 was 1.04 Billion KRW , up 166.18% from previous year.
  • NeoPharm CO., LTD.'s latest quarterly total debt in 2024 Q1 was 1 Billion KRW , down -4.41% from previous quarter.
  • NeoPharm CO., LTD. reported annual total debt of 393.57 Million KRW in 2022, down -27.05% from previous year.
  • NeoPharm CO., LTD. reported annual total debt of 539.5 Million KRW in 2021, down -87.42% from previous year.
  • NeoPharm CO., LTD. reported quarterly total debt of 1 Billion KRW for 2024 Q1, down -4.41% from previous quarter.
  • NeoPharm CO., LTD. reported quarterly total debt of 262.26 Million KRW for 2023 Q1, down -33.36% from previous quarter.

Annual Total Debt Chart of NeoPharm CO., LTD. (2023 - 2012)

Historical Annual Total Debt of NeoPharm CO., LTD. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 1.04 Billion KRW 166.18%
2022 393.57 Million KRW -27.05%
2021 539.5 Million KRW -87.42%
2020 4.29 Billion KRW -7.87%
2019 4.65 Billion KRW 1064.09%
2018 400 Million KRW 525.92%
2017 63.9 Million KRW 12.24%
2016 56.93 Million KRW 42.35%
2015 40 Million KRW 0.0%
2012 - KRW 0.0%

Peer Total Debt Comparison of NeoPharm CO., LTD.

Name Total Debt Total Debt Difference
Kolmar BNH Co., Ltd. 208.12 Billion KRW 99.497%